Eli Lilly and Company (Ticker: LLY) is a global leader in the pharmaceutical industry, headquartered in Indianapolis, Indiana, and operating offices in 18 countries. With a broad portfolio of innovative medicines across key therapeutic areas, including diabetes, oncology, and neurodegenerative diseases, Lilly's products are sold in approximately 125 countries worldwide. The company is committed to advancing scientific innovation and improving patient outcomes through research and development, positioning itself as a pivotal player in addressing complex healthcare challenges. As a market leader, Eli Lilly continues to focus on sustainable growth strategies while enhancing shareholder value through its robust pipeline and strategic partnerships.

NYSE

USA

HEALTHCARE

DRUG MANUFACTURERS - GENERAL

LILLY CORPORATE CENTER, INDIANAPOLIS, IN, UNITED STATES, 46285

December

$753 Billion

$24.8 Billion

54.79

15.33

$5.60

0.68%

0.461